{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hemoglobin-e-beta-thalassemia","columns":[{"gene":"","key":"population-cd0b1ffc1450683ea79b","label":"Hemoglobin E-beta-thalassemia syndrome","mondoId":"MONDO:0016491","onsetQualifier":null,"originColumnKey":"MONDO:0016491/ORPHA:231249","originalViews":[{"key":"MONDO:0016491/ORPHA:231249","label":"Hemoglobin E-beta-thalassemia syndrome","scopeLabel":"ORPHA:231249","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["7c483fb1f189c0f498df9148ff0c5db43cb4b58f7b86f55ae1c1cfb4865a961b","8faf6db3061c6916aa698bcec6a31da45578ae44615304ee31f1e1b1f62b14e9","9b14a06d438b539a1482f98ef61c688bf0ba2589ee13d8958728d5f75349be99","d00f590ca3d31728d169acbba6923c51751dcad92730f60ae6132b7b99fce1ee"],"recordQualifiers":{},"scopeLabel":"ORPHA:231249","sourceIds":["ORPHA:231249"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-cd0b1ffc1450683ea79b"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0011902","HP:0001903","HP:0002721","HP:0003281"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":4,"sourceGroups":{"orphanet":4}},"features":[{"hpoId":"HP:0011902","label":"Abnormal hemoglobin","primary":true},{"hpoId":"HP:0001903","label":"Anemia","primary":true},{"hpoId":"HP:0002721","label":"Immunodeficiency","primary":true},{"hpoId":"HP:0003281","label":"Increased circulating ferritin concentration","primary":true}],"ledeHtml":"Hemoglobin E - beta-thalassemia (HbE - BT) is a form of beta-thalassemia that results in a mild to severe clinical presentation ranging from a condition indistinguishable from beta-thalassemia major to a mild form of beta-thalassemia intermedia.","mondoId":"MONDO:0016491","node":{"canonicalSlug":"hemoglobin-e-beta-thalassemia","comparisons":[{"documentSha256":"7e7f0cead2a606a744ee264be3e03505096e1d2e2e6eaa2908f7756aa73da929","key":"legacy-hemoglobin-e-beta-thalassemia","kind":"legacy","label":"hemoglobin E-beta-thalassemia syndrome","memberIds":["MONDO:0016491"],"mondoId":"MONDO:0016491","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hemoglobin-e-beta-thalassemia.7e7f0cead2a606a744ee264be3e03505096e1d2e2e6eaa2908f7756aa73da929.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"hemoglobin E-beta-thalassemia syndrome","paragraphs":["Hemoglobin E - beta-thalassemia (HbE - BT) is a form of beta-thalassemia that results in a mild to severe clinical presentation ranging from a condition indistinguishable from beta-thalassemia major to a mild form of beta-thalassemia intermedia."],"scope":"exact","source":"MONDO","upstream":"Orphanet:231249","url":"https://monarchinitiative.org/MONDO:0016491"},"ownColumnKeys":["population-cd0b1ffc1450683ea79b"],"publication":"published","relationships":[{"kind":"parent","label":"beta-thalassemia and related diseases","mondoId":"MONDO:0017145","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Name scope not exact or reviewed","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/20609"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"7c483fb1f189c0f498df9148ff0c5db43cb4b58f7b86f55ae1c1cfb4865a961b","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:231249","disease_name":"Hemoglobin E-beta-thalassemia syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001903","is_excluded":false,"label":"Anemia","onset_id":null,"reference":"ORPHA:231249","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8faf6db3061c6916aa698bcec6a31da45578ae44615304ee31f1e1b1f62b14e9","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:231249","disease_name":"Hemoglobin E-beta-thalassemia syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002721","is_excluded":false,"label":"Immunodeficiency","onset_id":null,"reference":"ORPHA:231249","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9b14a06d438b539a1482f98ef61c688bf0ba2589ee13d8958728d5f75349be99","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:231249","disease_name":"Hemoglobin E-beta-thalassemia syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003281","is_excluded":false,"label":"Increased circulating ferritin concentration","onset_id":null,"reference":"ORPHA:231249","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d00f590ca3d31728d169acbba6923c51751dcad92730f60ae6132b7b99fce1ee","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:231249","disease_name":"Hemoglobin E-beta-thalassemia syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011902","is_excluded":false,"label":"Abnormal hemoglobin","onset_id":null,"reference":"ORPHA:231249","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0016491\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:231249</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Hemoglobin E - beta-thalassemia (HbE - BT) is a form of beta-thalassemia that results in a mild to severe clinical presentation ranging from a condition indistinguishable from beta-thalassemia major to a mild form of beta-thalassemia intermedia.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0016491\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"hemoglobin-e-beta-thalassemia","sourceDocuments":[{"name":"MONDO: hemoglobin E-beta-thalassemia syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0016491"}],"sourceNote":"","synonyms":["E-beta-thalassemia","HbE-beta-thalassemia syndrome"],"takeawayHtml":"","title":"hemoglobin E-beta-thalassemia syndrome"},"schemaVersion":1}
